Goto

Collaborating Authors

 sequence identity



Self Distillation Fine-Tuning of Protein Language Models Improves Versatility in Protein Design

Tavakoli, Amin, Murugan, Raswanth, Gokdemir, Ozan, Ramanathan, Arvind, Arnold, Frances, Anandkumar, Anima

arXiv.org Artificial Intelligence

Supervised fine-tuning (SFT) is a standard approach for adapting large language models to specialized domains, yet its application to protein sequence modeling and protein language models (PLMs) remains ad hoc. This is in part because high-quality annotated data are far more difficult to obtain for proteins than for natural language. We present a simple and general recipe for fast SFT of PLMs, designed to improve the fidelity, reliability, and novelty of generated protein sequences. Unlike existing approaches that require costly precompiled experimental datasets for SFT, our method leverages the PLM itself, integrating a lightweight curation pipeline with domain-specific filters to construct high-quality training data. These filters can independently refine a PLM's output and identify candidates for in vitro evaluation; when combined with SFT, they enable PLMs to generate more stable and functional enzymes, while expanding exploration into protein sequence space beyond natural variants. Although our approach is agnostic to both the choice of protein language model (PLM) and the protein system, we demonstrate its effectiveness with a genome-scale PLM (GenSLM) applied to the tryptophan synthase enzyme family. The supervised fine-tuned model generates sequences that are not only more novel but also display improved characteristics across both targeted design constraints and emergent protein property measures.


A Extraction methods

Neural Information Processing Systems

ESM-1v is pre-trained to output the probability for each possible amino acid at a masked position. At each position, we introduce a mask token and record the model's predicted In all cases, we assume an additive model when multiple mutations are present in a sequence. For example, if mutations are introduced at positions 3 and 6, then M = {3, 6}. This method performs best among the four. ESM-1v and MSA Transformer amortize compute cost into a single expensive pre-training run.





Decoding the dark proteome: Deep learning-enabled discovery of druggable enzymes in Wuchereria bancrofti

Shivakumar, Shawnak, Hernandez, Jefferson

arXiv.org Artificial Intelligence

Wuchereria bancrofti, the parasitic roundworm responsible for lymphatic filariasis, permanently disables over 36 million people and places 657 million at risk across 39 countries. A major bottleneck for drug discovery is the lack of functional annotation for more than 90 percent of the W. bancrofti dark proteome, leaving many potential targets unidentified. In this work, we present a novel computational pipeline that converts W. bancrofti's unannotated amino acid sequence data into precise four-level Enzyme Commission (EC) numbers and drug candidates. We utilized a DEtection TRansformer to estimate the probability of enzymatic function, fine-tuned a hierarchical nearest neighbor EC predictor on 4,476 labeled parasite proteins, and applied rejection sampling to retain only four-level EC classifications at 100 percent confidence. This pipeline assigned precise EC numbers to 14,772 previously uncharacterized proteins and discovered 543 EC classes not previously known in W. bancrofti. A qualitative triage emphasizing parasite-specific targets, chemical tractability, biochemical importance, and biological plausibility prioritized six enzymes across five separate strategies: anti-Wolbachia cell-wall inhibition, proteolysis blockade, transmission disruption, purinergic immune interference, and cGMP-signaling destabilization. We curated a 43-compound library from ChEMBL and BindingDB and co-folded across multiple protein conformers with Boltz-2. All six targets exhibited at least moderately strong predicted binding affinities below 1 micromolar, with moenomycin analogs against peptidoglycan glycosyltransferase and NTPase inhibitors showing promising nanomolar hits and well-defined binding pockets. While experimental validation remains essential, our results provide the first large-scale functional map of the W. bancrofti dark proteome and accelerate early-stage drug development for the species.